Home » Partner With Us » For Industry » COLLABORATING with Industry
SARC works collaboratively with pharmaceutical and biotech companies to explore the potential benefit of new agents. We have designed and conducted trials to assist in developing new drugs. We have conducted phase 1 trials with selected centers, and we have partnered on pilot phase 2 studies as well as registration phase 3 studies for FDA approval.
Because of the rarity of sarcoma, making progress in translational research requires the collaboration of many partners. SARC is unique in its ability to bring together the network of participants and components necessary to bring clinical trials to reality, through an ongoing process of discovery, development and delivery for delivering new and better options.
Sign up for our monthly SARC newsletter and updates on clinical trials.